at Zacks.com (Thu, 5:20PM)
Goldman Sachs removes Baxter International (BAX) from its Conviction Buy List after finding better opportunities in the healthcare sector. Analysts with the firm maintain their Buy rating, while clipping the price target on shares by a $1 to $59. Shares +0.4% premarket.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Zacks.com (Thu, 8:47AM)
at Zacks.com (Tue, 3:45PM)
at Zacks.com (Jan 21, 2015)
at Investor's Business Daily (Jan 16, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs